Tragara sees peachy Capoxigem future even as APRiCOT trial fails overall in NSCLC
07 June 2011
Pial Ganguli
Please Login to read the full article.
07 June 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- Data cast more doubt on Avastin's benefit in older NSCLC patients
- Easing of Japanese Tarceva restrictions in NSCLC set to raise pressure on Iressa
- Idera holds out hope for IMO-2055 after negative Phase II head and neck cancer data
- AVEO's unconvincing Phase II ficlatuzumab data point to need for further studies
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
